Brain Potential Indices of Novelty Processing Are Associated With Preference for Amphetamine

Experimental and Clinical Psychopharmacology

Volumn 18, Issue 6, 2010, Pages 470-488

  Gabbay, Frances H ^a   Duncan, Connie C ^a   McDonald, Craig G ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

Author keywords

D amphetamine preference; Event related potentials; N100; P3a; Reorienting negativity

Indexed keywords

DEXAMPHETAMINE;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; DRUG PREFERENCE; EVENT RELATED POTENTIAL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; TASK PERFORMANCE;

ADULT; ATTENTION; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOICE BEHAVIOR; COGNITION; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; YOUNG ADULT;

EID: 78650973878     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0021653     Document Type: Article

References (124)

1. Diagnostic and statistical manual of mental disorders 1987, American Psychiatric Association, Author, Washington, DC. 3rd ed., revised.
2. Antolin T., Berman S.M., Conner B.T., Ozkaragoz T.Z., Sheen C.L., Ritchie T.L., Noble E.P. D2 dopamine receptor (DRD2) gene, P300, and personality in children of alcoholics. Psychiatry Research 2009, 166:91-101.
3. Baving L., Rellum T., Laucht M., Schmidt M.H. Attentional enhancement to NoGo stimuli in anxious children. Journal of Neural Transmission 2004, 111:985-999.
4. Belmonte M.K., Yurgelun-Todd D.A. Functional anatomy of impaired selective attention and compensatory processing in autism. Brain Research: Cognitive Brain Research 2003, 17:651-664.
5. Berridge K.C., Robinson T.E., Aldridge J.W. Dissecting components of reward: 'liking', 'wanting', and learning. Current Opinion in Pharmacology 2009, 9:65-73.
6. Berti S., Schröger E. A comparison of auditory and visual distraction effects: Behavioral and event-related indices. Brain Research: Cognitive Brain Research 2001, 10:265-273.
7. Beste C., Saft C., Güntürkün O., Falkenstein M. Increased cognitive functioning in symptomatic Huntington's disease as revealed by behavioral and event-related potential indices of auditory sensory memory and attention. Journal of Neuroscience 2008, 28:11695-11702.
8. Bilder R.M., Volavka J., Lachman H.M., Grace A.A. The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 2004, 29:1943-1961.
9. Bradberry C.W., Gruen R.J., Berridge C.W., Roth R.H. Individual differences in behavioral measures: Correlations with nucleus accumbens dopamine measured by microdialysis. Pharmacology, Biochemistry, and Behavior 1991, 39:877-882.
10. Bramon E., Dempster E., Frangou S., McDonald C., Schoenberg P., MacCabe J.H., Walshe M., et al. Is there an association between the COMT gene and P300 endophenotypes?. European Psychiatry 2006, 21:70-73.
11. Bubic A., Bendixen A., Schubotz R.I., Jacobsen T., Schröger E. Differences in processing violations of sequential and feature regularities as revealed by visual event-related brain potentials. Brain Research 2010, 1317:192-202.
12. Budd T.W., Barry R.J., Gordon E., Rennie C., Michie P.T. Decrement of the. N1 auditory event-related potential with stimulus repetition: Habituation vs. refractoriness. International Journal of Psychophysiology 1998, 31:51-68.
13. Cain M.E., Dotson W.F., Bardo M.T. Individual differences in the effect of novel environmental stimuli prior to amphetamine self-administration in rats (Rattus norvegicus). Experimental and Clinical Psychopharmacology 2006, 14:389-401.
14. Cain M.E., Saucier D.A., Bardo M.T. Novelty seeking and drug use: Contribution of an animal model. Experimental and Clinical Psychopharmacology 2005, 13:367-375.
15. Calabresi P., Centonze D., Gubellini P., Pisani A., Bernardi G. Acetylcholine-mediated modulation of striatal function. Trends in Neuroscience 2000, 23:120-126.
16. Callaway E., Halliday R., Naylor H., Brandeis D. Clonidine and scopolamine: Differences and similarities in how they change human information processing. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1991, 15:497-502.
17. Ceballos N.A., Bauer L.O., Houston R.J. Recent EEG and ERP findings in substance abusers. Clinical EEG and Neuroscience 2009, 40:122-128.
18. Clearwater J.M., Kerr C.C., Rennie C.J., Robinson P.A. Neural mechanisms of ERP change: Combining insights from electrophysiology and mathematical modeling. Journal of Integrative Neuroscience 2008, 7:529-550.
19. Courchesne E., Hillyard S.A., Galambos R. Stimulus novelty, task relevance, and the visual evoked potential in man. Electroencephalography and Clinical Neurophysiology 1975, 39:131-143.
20. Cragg S.J. Meaningful silences: How dopamine listens to the ACh pause. Trends in Neuroscience 2006, 29:125-131.
21. Crottaz-Herbette S., Menon V. Where and when the anterior cingulate cortex modulates attentional response: Combined fMRI and ERP evidence. Journal of Cognitive Neuroscience 2006, 18:766-780.
22. Curran T., Dien J. Differentiating amodal familiarity from modality-specific memory processes: An ERP study. Psychophysiology 2003, 40:979-988.
23. Daly D.D., Pedley J.A. Current Practice of Clinical Neurophysiology: Electroencephalography 1990, Raven Press, New York. 2nd ed.
24. de Wit H. Individual differences in acute effects of drugs in humans: Their relevance to risk for abuse. National Institute on Drug Abuse Research Monograph No. 169. Laboratory behavioral studies of vulnerability to abuse 1998, 176-187. U.S. Department of Health and Human Services, National Institute on Drug Abuse, Rockville, MD, NIH Publication No. 98-4122. C.L. Wetherington, J.L. Falk (Eds.).
25. de Wit H., Uhlenhuth E.H., Johanson C.E. Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug and Alcohol Dependence 1986, 16:341-360.
26. Dien J., Frishkoff G.A. Introduction to principal components analysis of event-related potentials. Event-related potentials: A methods handbook 2005, 189-208. MIT Press, Cambridge, MA. T. Handy (Ed.).
27. Dien J., Spencer K.M., Donchin E. Parsing the late positive complex: Mental chronometry and the ERP components that inhabit the neighborhood of the P300. Psychophysiology 2004, 41:665-678.
28. Donchin E. Presidential address, 1980. Surprise!... surprise?. Psychophysiology 1981, 18:493-513.
29. Duncan C.C., Barry R.J., Connolly J.F., Fischer C., Michie P.T., Näätänen R., Polich J., et al. Event-related potentials in clinical research: Guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. Clinical Neurophysiology 2009, 120:1883-1908.
30. Duncan-Johnson C.C., Donchin E. The P300 component of the event-related brain potential as an index of information processing. Biological Psychology 1982, 14:1-52.
31. Escera C., Alho K., Winkler I., Näätänen R. Neural mechanisms of involuntary attention to acoustic novelty and change. Journal of Cognitive Neuroscience 1998, 10:590-604.
32. Escera C., Corral M.J. The distraction potential (DP), an electrophysiological tracer of involuntary attention control and its dysfunction. The cognitive neuroscience of individual differences 2003, 63-76. Bibliotheks-und Informationsystem der Universität Oldenburg, Oldenburg. I. Reinvang, M.W. Greenlee, M. Herrmann (Eds.).
33. Escera C., Corral M.J. Role of mismatch negativity and novelty-P3 in involuntary auditory attention. Journal of Psychophysiology 2007, 21:251-264.
34. Escera C., Yago E., Alho K. Electrical responses reveal the temporal dynamics of brain events during involuntary attention switching. European Journal of Neuroscience 2001, 14:877-883.
35. Espeseth T., Endestad T., Rootwelt H., Reinvang I. Nicotine receptor gene CHRNA4 modulates early event-related potentials in auditory and visual oddball target detection tasks. Neuroscience 2007, 147:974-985.
36. Fabiani M., Friedman D. Changes in brain activity patterns in aging: The novelty oddball. Psychophysiology 1995, 32:579-594.
37. Fabiani M., Kazmerski V.A., Cycowicz Y.M., Friedman D. Naming norms for brief environmental sounds: Effects of age and dementia. Psychophysiology 1996, 33:462-475.
38. Flagel S.B., Robinson T.E., Clark J.J., Clinton S.M., Watson S.J., Seeman P., Phillips P.E., et al. An animal model of genetic vulnerability to behavioral disinhibition and responsiveness to reward-related cues: Implications for addiction. Neuropsychopharmacology 2010, 35:388-400.
39. Flanagin B.A., Cook E.H., de Wit H. An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine response. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 2006, 141B:576-583.
40. Folstein J.R., Van Petten C. Influence of cognitive control and mismatch on the N2 component of the ERP: A review. Psychophysiology 2008, 45:152-170.
41. Foltin R.W., Fischman M.W. Assessment of abuse liability of stimulant drugs in humans: A methodological survey. Drug and Alcohol Dependence 1991, 28:3-48.
42. Ford J.M., White P.M., Csernansky J.G., Faustman W.O., Roth W.T., Pfefferbaum A. ERPs in schizophrenia: Effects of antipsychotic medication. Biological Psychiatry 1994, 36:153-170.
43. Freedman R. Electrophysiological phenotypes. Methods in Molecular Medicine 2003, 77:215-225.
44. Friedman D., Cycowicz Y.M., Gaeta H. The novelty P3: An event-related brain potential (ERP) sign of the brain's evaluation of novelty. Neuroscience and Biobehavior Review 2001, 25:355-373.
45. Friedman D., Simpson G.V. ERP amplitude and scalp distribution to target and novel events: Effects of temporal order in young, middle-aged and older adults. Brain Research: Cognitive Brain Research 1994, 2:49-63.
46. Gabbay F.H. Variations in affect following amphetamine and placebo: Markers of stimulant drug preference. Experimental and Clinical Psychopharmacology 2003, 11:91-101.
47. Gallinat J., Bajbouj M., Sander T., Schlattmann P., Xu K., Ferro E.F., Goldman D., et al. Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biological Psychiatry 2003, 54:40-48.
48. Goldman-Rakic P.S. The cortical dopamine system: Role in memory and cognition. Advances in Pharmacology 1998, 42:707-711.
49. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: Etymology and strategic intentions. American Journal of Psychiatry 2003, 160:636-645.
50. Groman S.M., James A.S., Jentsch J.D. Poor response inhibition: At the nexus between substance abuse and attention deficit/hyperactivity disorder. Neuroscience & Behavioral Reviews 2009, 35:690-698.
51. Gumenyuk V., Korzyukov O., Escera C., Hämäläinen M., Huotilainen M., Häyrinen T., Oksanen H., et al. Electrophysiological evidence of enhanced distractibility in ADHD children. Neuroscience Letters 2005, 374:212-217.
52. Hadwin J.A., Garner M., Perez-Olivas G. The development of information processing biases in childhood anxiety: A review and exploration of its origins in parenting. Clinical Psychology Review 2006, 26:876-894.
53. Hamidovic A., Dlugos A., Palmer A.P., de Wit H. Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of d-amphetamine: An exploratory pharmacogenetic study using healthy volunteers. Behavior Genetics 2010, 40:255-261.
54. Hill S.Y. Trajectories of alcohol use and electrophysiological and morphological indices of brain development: Distinguishing causes from consequences. Annals of the New York Academy of Sciences 2004, 1021:245-259.
55. Hogan A.M., Butterfield E.L., Phillips L., Hadwin J.A. Brain response to unexpected novel noises in children with low and high trait anxiety. Journal of Cognitive Neuroscience 2007, 19:25-31.
56. Holeckova I., Fischer C., Giard M.H., Delpuech C., Morlet D. Brain responses to a subject's own name uttered by a familiar voice. Brain Research 2006, 1082:142-152.
57. Horváth J., Roeber U., Bendixen A., Schröger E. Specific or general? The nature of attention set changes triggered by distracting auditory events. Brain Research 2008, 1229:193-203.
58. Horváth J., Winkler I., Bendixen A. Do N1/MMN, P3a, and RON form a strongly coupled chain reflecting the three stages of auditory distraction?. Biological Psychology 2008, 79:139-147.
59. Iacono W.G., Malone S.M., McGue M. Behavioral disinhibition and the development of early-onset addiction: Common and specific influences. Annual Review of Clinical Psychology 2008, 4:325-348.
60. Iwanami A., Isono H., Okajima Y., Kamijima K. Auditory event-related potentials in panic disorder. European Archives of Psychiatry and Clinical Neuroscience 1997, 247:107-111.
61. Jankowiak S., Berti S. Behavioral and event-related potential distraction effects with regularly occurring auditory deviants. Psychophysiology 2007, 44:79-85.
62. Jasper H.H. The ten-twenty electrode system of the International Federation. Electroencephalography and Clinical Neurophysiology 1958, 10:371-375.
63. Javitt D.C. Intracortical mechanisms of mismatch negativity dysfunction in schizophrenia. Audiology and Neurotology 2000, 5:207-215.
64. Jennings J.R., Wood C.C. Letter: The epsilon-adjustment procedure for repeated measures analyses of variance. Psychophysiology 1976, 13:277-278.
65. Johanson C.E., Kilgore K., Uhlenhuth E.H. Assessment of dependence potential of drugs in humans using multiple indices. Psychopharmacology 1983, 81:144-149.
66. Johanson C.E., Uhlenhuth E.H. Drug preference and mood in humans: d-Amphetamine. Psychopharmacology 1980, 71:275-279.
67. Kähkönen S., Ahveninen J. Combination of magneto- and electroencephalography in studies of monoamine modulation on attention. Clinical Pharmacology 2002, 24:27-34.
68. Kähkönen S., Ahveninen J., Pekkonen E., Kaakkola S., Huttunen J., Ilmoniemi R.J., Jääskeläinen I.P. Dopamine modulates involuntary attention shifting and reorienting: An electromagnetic study. Clinical Neurophysiology 2002, 113:1894-1902.
69. Kalivas P. Cocaine and amphetamine-like psychostimulants: Neurocircuitry and glutmate neuroplasticicity. Dialogues in Clinical Neuroscience 2007, 9:389-397.
70. Kam J.W.Y., Dao E., Farley J., Fitzpatrick K., Smallwood J., Schooler J.W., Handy T.C. Slow fluctuations in attentional control of sensory cortex. Journal of Cognitive Neuroscience 2011, 23:460-470.
71. Katayama J., Polich J. Stimulus context determines P3a and P3b. Psychophysiology 1998, 35:23-33.
72. Klebaur J.E., Bevins R.A., Segar T.M., Bardo M.T. Individual differences in behavioral responses to novelty and amphetamine self-administration in male and female rats. Behavioral Pharmacology 2001, 12:267-275.
73. Knight R.T. Decreased response to novel stimuli after prefrontal lesions in man. Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section 1984, 59:9-20.
74. Knott V., Lapierre Y.D., Fraser G., Johnson N. Auditory evoked potentials in panic disorder. Journal of Psychiatric Neuroscience 1991, 16:215-220.
75. Korostenskaja M., Kähkönen S. What do ERPs and ERFs reveal about the effect of antipsychotic treatment on cognition in schizophrenia?. Current Pharmaceutical Design 2009, 15:2573-2593.
76. Leung S., Croft R.J., Guille V., Scholes K., O'Neill B.V., Phan K.L., Nathan P.J. Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants. Psychopharmacology 2010, 208:233-244.
77. Levy F. Dopamine vs noradrenaline: Inverted-U effects and ADHD theories. Australian and New Zealand Journal of Psychiatry 2009, 43:101-108.
78. Li T., Chen C.K., Hu X., Ball D., Lin S.K., Chen W., Sham P.C., et al. Association analysis of the DRD4 and COMT genes in methamphetamine abuse. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2004, 129B:120-124.
79. Lott D.C., Kim S.-J., Cook E.H., de Wit H. Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 2005, 30:602-609.
80. Marco-Pallarés J., Nager W., Krämer U.M., Cunillera T., Càmara E., Cucurell D., Schüle R., et al. Neurophysiological markers of novelty processing are modulated by COMT and DRD4 genotypes. Neuroimage 2010, 53:962-969.
81. Mattay V.S., Goldberg T.E., Fera F., Hariri A.R., Tessitore A., Egan M.F., Kolachana B., et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences, USA 2003, 100:6186-6191.
82. McDonald C.M., Gabbay F.H., Rietschel J., Duncan C.C. Evidence for a new late positive ERP component in an attended novelty oddball task. Psychophysiology 2010, 47:809-813.
83. Mena-Segovia J., Winn P., Bolam J.P. Cholinergic modulation of midbrain dopaminergic systems. Brain Research Reviews 2008, 58:265-271.
84. Miller G.A., Lutzenberger W., Elbert T. The linked reference issue in EEG and ERP recording. Journal of Psychophysiology 1991, 5:273-276.
85. Näätänen R., Paavilainen P., Rinne T., Alho K. The mismatch negativity (MMN) in basic research of central auditory processing: A review. Clinical Neurophysiology 2007, 118:2544-2590.
86. Näätänen R., Picton T. The N1 wave of the human electric and magnetic response to sound: A review and an analysis of the component structure. Psychophysiology 1987, 24:375-425.
87. Nieuwenhuis S., Aston-Jones G., Cohen J.D. Decision making, the P3, and the locus coeruleus-norepinephrine system. Psychological Bulletin 2005, 131:510-532.
88. Parasuraman R., Espeseth T. Genetic and neuroimaging studies of cholinergic and neurotrophic modulation of visual attention. Progress in Natural Science 2007, 17:7-18.
89. Pekkonen E., Hirvonen J., Jääskeläinen I.P., Kaakkola S., Huttunen J. Auditory sensory memory and the cholinergic system: Implications for Alzheimer's disease. Neuroimage 2001, 14:376-382.
90. Pekkonen E., Jääskeläinen I.P., Kaakkola S., Ahveninen J. Cholinergic modulation of preattentive auditory processing in aging. Neuroimage 2005, 27:387-392.
91. Piazza P.V., Deminière J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989, 245:1511-1513.
92. Piazza P.V., Rougé-Pont F., Deminière J.M., Kharoubi M., Le Moal M., Simon H. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Research 1991, 567:169-174.
93. Pierre P.J., Vezina P. Predisposition to self-administer amphetamine: The contribution of response to novelty and prior exposure to the drug. Psychopharmacology (Berlin) 1997, 129:277-284.
94. Polich J. Updating P300: An integrative theory of P3a and P3b. Clinical Neurophysiology 2007, 118:2128-2148.
95. Polich J., Criado J.R. Neuropsychology and neuropharmacology of P3a and P3b. International Journal of Psychophysiology 2006, 60:172-185.
96. Polo M.D., Escera C., Yago E., Alho K., Gual A., Grau C. Electrophysiological evidence of abnormal activation of the cerebral network of involuntary attention in alcoholism. Clinical Neurophysiology 2003, 114:134-146.
97. Rebec G.V. Behavioral electrophysiology of psychostimulants. Neuropsychopharmacology 2006, 31:2341-2348.
98. Robins L., Helzer J., Cottler L., Goldring E. NIMH Diagnostic Interview Schedule, Version III Revised (DIS-III-R) 1989, Washington University, St. Louis, MO.
99. Roye A., Jacobsen T., Schröger E. Personal significance is encoded automatically by the human brain: An event-related potential study with ringtones. European Journal of Neuroscience 2007, 26:784-790.
100. Rubinstein M., Cepeda C., Hurst R.S., Flores-Hernandez J., Ariano M.A., Falzone T.L., Kozell L.B., et al. Dopamine D4 receptor-deficient mice display cortical hyperexcitability. The Journal of Neuroscience 2001, 21:3756-3763.
101. Saigusa T., Tuinstra T., Koshikawa N., Cools A.R. High and low responders to novelty: Effects of a catecholamine synthesis inhibitor on novelty-induced changes in behaviour and release of accumbal dopamine. Neuroscience 1999, 88:1153-1163.
102. Schröger E., Giard M.H., Wolff C. Auditory distraction: Event-related potential and behavioural indices. Clinical Neurophysiology 2000, 111:1450-1460.
103. Schröger E., Wolff C. Attentional orienting and reorienting is indicated by human event-related brain potentials. Neuroreport 1998, 9:3355-3358.
104. Simons R.F., Graham F.K., Miles M.A., Chen X. On the relationship of P3a and the novelty-P3. Biological Psychology 2001, 56:207-218.
105. Singh S.M., Basu D. The P300 event-related potential and its possible role as an endophenotype for studying substance use disorders: A review. Addiction Biology 2009, 14:298-309.
106. 2 dopamine receptor TaqI B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Archives of General Psychiatry 1992, 49:723-727.
107. Sokhadze E., Baruth J., Tasman A., Sears L., Mathai G., El-Baz A., Casanoca M.F. Event-related potential study of novelty processing abnormalities in autism. Applied Psychophysiology and Biofeedback 2009, 34:37-51.
108. Soltani M., Knight R.T. Neural origins of the P300. Critical Reviews of Neurobiology 2000, 14:199-224.
109. Spencer K.M., Dien J., Donchin E. A componential analysis of the ERP elicited by novel events using a dense electrode array. Psychophysiology 1999, 36:409-414.
110. Spencer K.M., Dien J., Donchin E. Spatiotemporal analysis of the late ERP responses to deviant stimuli. Psychophysiology 2001, 38:343-358.
111. Stöhr T., Schulte Wermeling D., Weiner I., Feldon J. Rat strain differences in open-field behavior and the locomotor stimulating and rewarding effects of amphetamine. Pharmacology, Biochemistry, and Behavior 1998, 59:813-818.
112. Strobel A., Debener S., Anacker K., Müller J., Lesch K.P., Brocke B. Dopamine D4 receptor exon III genotype influence on the auditory evoked novelty P3. Neuroreport 2004, 15:2411-2415.
113. Sussman E., Winkler I., Schröger E. Top-down control over involuntary attention switching in the auditory modality. Psychonomic Bulletin Review 2003, 10:630-637.
114. Tsai S.J., Yu Y.W., Chen T.J., Chen M.C., Hong C.J. Association analysis for dopamine D3 receptor, dopamine D4 receptor and dopamine transporter genetic polymorphisms and P300 event-related potentials for normal young females. Psychiatric Genetics 2003, 13:51-53.
115. Uhl G.R., Drgon T., Johnson C., Li C.Y., Contoreggi C., Hess J., Naiman D., et al. Molecular genetics of addiction and related heritable phenotypes: Genome-wide association approaches identify " connectivity constellation" and drug target genes with pleiotropic effects. Annals of the New York Academy of Sciences 2008, 1141:318-381.
116. Volkow N.D., Fowler J.S., Wang G.J., Swanson J.M. Dopamine in drug abuse and addiction: Results from imaging studies and treatment implications. Molecular Psychiatry 2004, 9:557-569.
117. Wang E., Ding Y.C., Flodman P., Kidd J.R., Kidd K.K., Grady D.L., Ryder O.A., et al. The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus. American Journal of Human Genetics 2004, 75:931-944.
118. Watson T.D., Petrakis I.L., Edgecombe J., Perrino A., Krystal J.H., Mathalon D.H. Modulation of the cortical processing of novel and target stimuli by drugs affecting glutamate and GABA neurotransmission. The International Journal of Neuropsychopharmacology 2009, 12:357-370.
119. Wetzel N., Widmann A., Berti S., Schröger E. The development of involuntary and voluntary attention from childhood to adulthood: A combined behavioral and event-related potential study. Clinical Neurophysiology 2006, 117:2191-2203.
120. Wetzel N., Widmann A., Schröger E. The cognitive control of distraction by novelty in children aged 7-8 and adults. Psychophysiology 2009, 46:607-616.
121. Woestenburg J.C., Verbaten M.N., Slangen J.L. The removal of the eye-movement artifact from the EEG by regression analysis in the frequency domain. Biological Psychology 1983, 16:127-147.
122. Yago E., Escera C., Alho K., Giard M.H., Serra-Grabulosa J.M. Spatiotemporal dynamics of the auditory novelty-P3 event-related brain potential. Cognitive Brain Research 2003, 16:383-390.
123. Yue C., Wu T., Deng W., Wang G., Sun X. Comparison of visual evoked-related potentials in healthy young adults of different catechol-O-methyltransferase genotypes in a continuous 3-back task. Neuroreport 2009, 25:521-524.
124. Zuckerman M., Kuhlman D.M. Personality and risk-taking: Common biosocial factors. Journal of Personality 2000, 68:999-1029.